NBIS vs PG: Which Is the Better Buy?
Side-by-side comparison of Nebius Group N.V. and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
Nebius Group N.V. · Technology
$218.99
+11.9% upside to fair value
Med Conviction
Grade C+
VS
The Procter & Gamble Company · Consumer Defensive
$150.38
+10.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
NBIS has more upside to fair value
(+11.9%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
NBIS |
PG |
| Current Price |
$218.99 |
$150.38 |
| Fair Value Estimate |
$245.00 |
$165.39 |
| Upside to Fair Value |
+11.9%
|
+10.0%
|
| Market Cap |
$52.6B |
$350.2B |
| Forward P/E |
—
|
21.5x
|
| EV / EBITDA |
—
|
15.1x
|
| Price / Sales |
59.9x
|
4.0x
|
| Price / FCF |
—
|
23.3x
|
| Revenue Growth YoY |
+684.0%
|
+7.4%
|
| Gross Margin |
48.0%
|
50.3%
|
| Operating Margin |
-68.8%
|
23.2%
|
| Return on Equity |
—
|
31.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
-4.7%
|
4.29%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Nebius Group is a fast-scaling neocloud GPU infrastructure provider spun out of Yandex's international assets, positioned at the center of the AI compute buildout with a validated capital relationship to Nvidia, which holds a 9.3% stake following a $2 billion investment. Revenue grew 684% year over year in Q1 2026 to $399 million, core AI cloud ARR reached $1.92 billion, and the company has locke…
The Procter & Gamble Company is a leading global consumer defensive company specializing in household and personal products with a strong portfolio across fabric care, baby and family care, beauty, health care, and grooming. The business quality is high, supported by a durable competitive moat from strong brands, consistent earnings growth, and prudent capital allocation emphasizing dividends and…
Accumulation Zones
| Metric |
NBIS |
PG |
| Zone Low |
$184.00 |
$124.04 |
| Zone High |
$208.00 |
$140.58 |
| In Buy Zone? |
No
|
No
|